Sheng Xiao

1.8k total citations · 1 hit paper
39 papers, 1.4k citations indexed

About

Sheng Xiao is a scholar working on Surgery, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Sheng Xiao has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 11 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Sheng Xiao's work include Sarcoma Diagnosis and Treatment (4 papers), Sports injuries and prevention (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Sheng Xiao is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Sports injuries and prevention (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Sheng Xiao collaborates with scholars based in China, United States and Japan. Sheng Xiao's co-authors include Jonathan A. Fletcher, Brian P. Rubin, George D. Demetri, Samuel Singer, Marcia L. Lux, Christopher D.�M. Fletcher, Jonathan A. Fletcher, Yu Li, Morris F. White and Qing Chang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sheng Xiao

35 papers receiving 1.4k citations

Hit Papers

KIT Extracellular and Kin... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
    2000 538 citations Marcia L. Lux, Brian P. Rubin et al. American Journal Of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Xiao China 12 484 423 353 352 285 39 1.4k
Fumiyoshi Fujishima Japan 22 495 1.0× 101 0.2× 452 1.3× 728 2.1× 83 0.3× 195 1.8k
Koichi Aiura Japan 25 570 1.2× 173 0.4× 231 0.7× 644 1.8× 75 0.3× 79 1.7k
Masaru Nakano Japan 15 196 0.4× 40 0.1× 175 0.5× 134 0.4× 173 0.6× 83 915
Toshihiro Suga Japan 16 300 0.6× 115 0.3× 316 0.9× 575 1.6× 64 0.2× 61 1.4k
Kenichiro Kusano Japan 14 205 0.4× 35 0.1× 513 1.5× 221 0.6× 387 1.4× 20 1.8k
A. Beham Germany 20 219 0.5× 151 0.4× 354 1.0× 389 1.1× 123 0.4× 69 1.3k
Marian Danilewicz Poland 18 155 0.3× 24 0.1× 321 0.9× 195 0.6× 181 0.6× 166 1.3k

Countries citing papers authored by Sheng Xiao

Since Specialization
Citations

This map shows the geographic impact of Sheng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Xiao more than expected).

Fields of papers citing papers by Sheng Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Xiao. The network helps show where Sheng Xiao may publish in the future.

Co-authorship network of co-authors of Sheng Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Xiao. A scholar is included among the top collaborators of Sheng Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Xiao. Sheng Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Ming, et al.. (2025). Midterm comparative result of absorbable screws and metal screws in pediatric medial humeral epicondyle fracture. Journal of Orthopaedic Science. 30(5). 824–829.
2.
Zhang, Dongmei, Meiqi Zhao, Ping Jiang, et al.. (2025). RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis. Journal of Translational Medicine. 23(1). 244–244. 1 indexed citations
3.
Sun, Jiying, Huihui Yao, Lijun Meng, et al.. (2024). The ketogenic diet modulates tumor-associated neutrophil polarization via the AMOT-YAP/TAZ axis to inhibit colorectal cancer progression. Pharmacological Research. 210. 107494–107494. 4 indexed citations
4.
Wan, Dong, Si Chen, Huafei Chen, et al.. (2024). Case report: Germline CHEK2 mutation is associated with a giant cell glioblastoma. Frontiers in Oncology. 14. 1361928–1361928.
5.
Chen, Ping, Han Zhang, Liying Zhang, et al.. (2023). IGH::CD274 (PD‐L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication. SHILAP Revista de lepidopterología. 4(2). 442–445. 2 indexed citations
6.
Liu, Can, et al.. (2023). Effects of different pelvic osteotomy surgeries on acetabular center and pelvic morphology. Journal of Orthopaedic Surgery and Research. 18(1). 568–568. 5 indexed citations
7.
Huang, Dan, et al.. (2023). Effectiveness of platelet-rich plasma in the treatment of Achilles tendon disease. World Journal of Orthopedics. 14(6). 485–501. 7 indexed citations
8.
Chen, Yanming, et al.. (2022). Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor. Frontiers in Oncology. 12. 1064817–1064817. 1 indexed citations
9.
10.
Hu, Yongbin, et al.. (2021). Loss of 5'ALK leads to better response to crizotinib in sarcomas with ALK rearrangement.. Journal of Clinical Oncology. 39(15_suppl). e23554–e23554. 1 indexed citations
11.
Pan, Jian, et al.. (2019). A renal cell carcinoma with EWSR1‐TFE3 fusion gene. Genes Chromosomes and Cancer. 59(5). 325–329. 6 indexed citations
12.
Wu, Jie, Sheng Xiao, Miaomiao Yuan, et al.. (2018). PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis. Molecular Medicine Reports. 19(1). 75–84. 15 indexed citations
13.
Wong, Waihay J., et al.. (2015). Alternate PAX3‐FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes and Cancer. 55(1). 25–29. 54 indexed citations
14.
Wu, Hongjin, et al.. (2014). AIF Downregulation and Its Interaction with STK3 in Renal Cell Carcinoma. PLoS ONE. 9(7). e100824–e100824. 11 indexed citations
15.
Wang, Junpeng, Zhihong Ren, Yanmei Xu, et al.. (2011). Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets. American Journal Of Pathology. 180(1). 221–234. 84 indexed citations
16.
Chang, Martin C., Sheng Xiao, & Vânia Nosé. (2007). Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression. Human Pathology. 38(5). 732–740. 6 indexed citations
17.
Xiao, Sheng, Kanghua Li, & Hongbin Lü. (2003). [Effect of ligustrazine on the expression of Bcl-2 protein and apoptosis in rabbit articular chondrocytes in monolayer culture].. PubMed. 28(3). 224–6. 6 indexed citations
18.
Lux, Marcia L., Brian P. Rubin, George D. Demetri, et al.. (2000). KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors. American Journal Of Pathology. 156(3). 791–795. 538 indexed citations breakdown →
19.
Xiao, Sheng, et al.. (1992). Cytogenetic studies of eight primary gastric cancers. Cancer Genetics and Cytogenetics. 58(1). 79–84. 25 indexed citations
20.
Xiao, Sheng, et al.. (1992). Cytogenetic abnormalities in a squamous cell carcinoma of the penis. Cancer Genetics and Cytogenetics. 64(2). 139–141. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumiyoshi Fujishima Breakdown of academic impact, for papers by Koichi Aiura Breakdown of academic impact, for papers by Masaru Nakano Breakdown of academic impact, for papers by Toshihiro Suga Breakdown of academic impact, for papers by Kenichiro Kusano Breakdown of academic impact, for papers by A. Beham Breakdown of academic impact, for papers by Marian Danilewicz
Rankless by CCL
2026